Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.36 USD | +1.20% | +2.13% | +34.40% |
20/05 | Whitefort Capital Management Sends an Open Letter to Shareholders of Arbutus Biopharma | CI |
17/05 | Sector Update: Health Care Stocks Mixed Late Afternoon | MT |
Sales 2024 * | 9.04M 6.62M 550M | Sales 2025 * | 8.08M 5.92M 492M | Capitalization | 865M 634M 52.69B |
---|---|---|---|---|---|
Net income 2024 * | -98M -71.79M -5.97B | Net income 2025 * | -102M -74.72M -6.21B | EV / Sales 2024 * | 95.7 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 107 x |
P/E ratio 2024 * |
-8.58
x | P/E ratio 2025 * |
-8.54
x | Employees | 73 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 77.71% |
Latest transcript on Arbutus Biopharma Corporation
1 day | +1.20% | ||
1 week | +2.13% | ||
1 month | +25.37% | ||
3 months | +20.43% | ||
6 months | +65.52% | ||
Current year | +34.40% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 50 | 01/14/01 | |
David Hastings
DFI | Director of Finance/CFO | 62 | 11/18/11 |
Karen Sims
CTO | Chief Tech/Sci/R&D Officer | 53 | 01/17/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 68 | 01/14/01 | |
James Meyers
BRD | Director/Board Member | 59 | 23/18/23 |
Daniel Burgess
BRD | Director/Board Member | 62 | 23/17/23 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 0 M€ | 0.00% | - | |
0.03% | 0 M€ | 0.00% | - | |
0.03% | 2 M€ | -.--% | ||
0.02% | 7 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
31/24/31 | 3.36 | +1.20% | 831,299 |
30/24/30 | 3.32 | -1.19% | 1,571,356 |
29/24/29 | 3.36 | +0.30% | 1,030,765 |
28/24/28 | 3.35 | +1.82% | 1,066,474 |
Delayed Quote Nasdaq, May 01, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+34.40% | 634M | |
-1.85% | 89.87B | |
-3.95% | 37.57B | |
+63.05% | 26.47B | |
-22.14% | 14.25B | |
-7.96% | 12.99B | |
-9.33% | 11.93B | |
-46.33% | 10.84B | |
+5.77% | 9.11B | |
-19.53% | 7.32B |
- Stock Market
- Equities
- ABUS Stock